
About Amneal
Amneal is a publicly listed company based in Bridgewater (United States) founded in 2002. Manufacturer of generics formulations. The company has 8,300 employees. Amneal has completed 7 acquisitions, including AvKARE, Epsilon Pharmaceuticals and Gemini Laboratories. Its website amneal.com draws about 27 thousand monthly visits. Amneal offers products and services including Generic Products, Specialty Products, and Biosciences Products. Its focus areas include Traditional Pharmaceuticals and Diversified. Its legal entity is Amneal Pharmaceuticals LLC.
Company details
Amneal Pharmaceuticals is a fully-integrated pharmaceutical company focused on the development, manufacture, and distribution of generic and specialty drug products. The company has an extensive portfolio of approximately 250 generic medicines and is expanding its portfolio to include complex dosage forms including biosimilars in a broad range of therapeutic areas. The company also markets a portfolio of branded pharmaceutical products through its specialty segment focused principally on the central nervous system and endocrine disorders.
- Headquarters Bridgewater, United States
- Employees 8,300
- Stage Public
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Phone•••• ••••
- Website amneal.com
- Social LinkedIn X Facebook YouTube
- Legal Name Amneal Pharmaceuticals, Inc.
- Annual Revenue$3.02 B (USD)8.05as on Dec 31, 2025
- Net Profit$72.06 M (USD)as on Dec 31, 2025
- EBITDA$646.66 M (USD)9.7as on Dec 31, 2025
- Latest Funding Round$19.2M (USD), Post-IPO
Nov 2018
- InvestorsNorthern Trust
& 2 more
- Employee Count8,300
- Investments & AcquisitionsAvKARE
& 6 more
Products & Services of Amneal
Amneal offers a comprehensive portfolio of products and services, including Generic Products, Specialty Products, and Biosciences Products.
Essential generic medicines for treating various common health conditions
Innovative drugs for specific diseases like Parkinson's and oncology
Advanced biosimilars for institutional and patient use worldwide
Apps and channels of Amneal
its YouTube channel Amneal Pharmaceuticals has 3.53K subscribers and 30 videos.
Videos from Amneal
The most watched videos on Amneal's YouTube channel, Amneal Pharmaceuticals (3.53K subscribers). Click a video to play it here.
More on Amneal Pharmaceuticals.
Funding Insights of Amneal
- Total Rounds 3
- Last Round Post-IPO — $19.2M
- Investors Count 3
All 3 funding rounds of Amneal with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2018 | $19.2M | Post-IPO | – | – | |
| Feb 2015 | $250M | Debt – Conventional | – | – | |
| Jun 2005 | Series A | – | – |
3 investors in total: 3 institutional.
Investors in Amneal
Amneal has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Northern Trust, GE Capital and Tarsadia.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital and private equity are directed toward multiple sectors. | tarsadia.com | Newport Beach, United States | ||
Financial and wealth management services are provided worldwide. | 1889 | northerntrust.com | Chicago, United States | |
Commercial aircraft and equipment leasing and lending services are provided. | 1932 | gecapital.com | United States |
Investor details for Amneal
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Amneal
137 people are tracked at Amneal (55 in leadership, 9 in board & advisors, 73 in team); the tracked headcount is 8,300.
| Name | Role | Group |
|---|---|---|
Sarah Klein | Director, Corporate Counsel - Litigation | Leadership |
Rose Sobreiro | Director Compensation | Leadership |
Karan Shroff | Head Of Finance | Leadership |
Robert Miranda | Director, Revenue Accounting | Leadership |
Chintu Patel | Co-CEO | Leadership |
Divyang Kansara | General Manager Finance & Accounts | Leadership |
Edwin Medina | Director - Accounts Payable & Travel Services | Leadership |
Gunjan Vanarase | Director Of Compliance (corporate Quality) | Leadership |
Jane Budson | Senior Director, HR Operations, HRIS & Payroll | Leadership |
Yiza Soto | Director Of Fp&a | Leadership |
Rajesh Pandya | Associate Vice President | Leadership |
Manish Shah | Director | Leadership |
Mathew Joseph | Head HR - Commercial Ops (india And Emerging Markets) | Leadership |
Sherry Feis | Executive Assistant To Co-ceo | Leadership |
Timothy Biggiani | Sr. Director, Talent Acquisition | Leadership |
Scott Gamache | Director, Technical Accounting | Leadership |
Tom Gangone | Human Resources Director | Leadership |
Anne Haumacher | Director Learning & Development | Leadership |
Ruby Russell | Associate Director, Tax Compliance | Leadership |
Tony Dimeo | Vp, Investor Relations | Leadership |
117 more people are available in the full profile.
Complete people profiles for Amneal
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Amneal
Amneal is a publicly listed company on the NASDAQ with ticker symbol AMRX in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date20 Jan 2009
- Listed onNASDAQ: AMRX
- Listed entityAmneal Pharmaceuticals, Inc.
- Exchange sectorHealth technology
- ISINUS03168L1052
- Share price$19.57 (-2.3% on the day) · 2026-10-13
- Market capitalisation$6.25B
- Price to earnings40.8
- EPS (diluted, trailing year)$0.48
- Volume (last session)5,001,278
Financials of Amneal
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | $3.02B | $72.1M | $646.7M |
| 2024 | $2.79B | -$116.9M | $589.5M |
| 2023 | $2.39B | -$84.0M | $492.4M |
| 2022 | $2.21B | -$130.0M | $440.6M |
| 2021 | $2.09B | $10.6M | $457.7M |
Detailed financial statements for Amneal
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Amneal
Amneal has strategically engaged in corporate development activities, having acquired 7 companies. Notable acquisitions include AvKARE, Epsilon Pharmaceuticals and Gemini Laboratories.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Biosimilar medicines are developed through integrated biopharmaceutical operations. | kashivbiosciences.com | Piscataway, United States | 2010 | Apr 2026 | •••• | |
Therapeutic products are developed and manufactured by Puniska. | puniska.com | Ahmedabad, India | 2017 | Nov 2021 | $93M | |
Therapeutic solutions for rare diseases are developed. | kashivsp.com | Bridgewater, United States | 2020 | Jan 2021 | $70M | |
Pharmaceuticals and infection control products are distributed by AvKARE. | avkare.com | Pulaski, United States | 2007 | Dec 2019 | $220M | |
Drugs are distributed by R&S Northeast in the pharmaceutical sector. | rsnortheast.com | Philadelphia, United States | 1973 | Dec 2019 | $120M | |
Science-based nutrition products are developed for infants, children, and adults. | geminilabs.com | Bridgewater, United States | 2013 | May 2018 | •••• | |
Generic oncology pharmaceuticals are manufactured on a contract basis. | epsilonpharma.com | Hyderabad, India | 2010 | Jun 2014 | $13.5M |
Complete acquisition details for Amneal
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Amneal
11 dated milestones of Amneal across 24 years, from founding to its latest funding, stage changes and deals.
- Founded Amneal is founded.
- Funding First funding round.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Epsilon Pharmaceuticals.
- Acquisition Acquires Gemini Laboratories.
- Funding Latest funding round, Post-IPO, of $19.2M.
- Acquisition Acquires AvKARE.
- Acquisition Acquires R&S Northeast.
- Acquisition Acquires Kashiv Specialty Pharmaceuticals.
- Acquisition Acquires Puniska.
- Acquisition Acquires Kashiv BioSciences.
Web traffic of Amneal
The website of Amneal (amneal.com) receives about 26.8K visits a month and ranks #959,075 among all websites worldwide, #1,166 in Biotechnology and Pharmaceuticals.
- Monthly visits26.8K
▼ 6.9% vs previous month
- Unique visitors15.1K
per month
- Global rank#959,075
among all websites
- Category rank#1,166
Health · Biotechnology and Pharmaceuticals
- Bounce rate37%
- Pages per visit2.1
- Average visit1 min 30 sec
- DevicesDesktop 35% · Mobile 65%
Websites whose visitors overlap most with Amneal. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| parpharm.com | 100% | View details | |||
| geminipharm.com | 90% | #2,449,109 | View details | ||
cebert.com | cebert.com | 89% | – | ||
| cpc.com | 86% | 5.7K | #3,776,348 | View details | |
| tevausa.com | 86% | 63.7K | #703,532 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for Amneal
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Traditional Health & Nutrition
3 companies that operate in the same segment as Amneal (Traditional Health & Nutrition) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Biosimilar therapeutics are developed for oncology and autoimmune diseases. | 2010 | Redwood City, California, United States | USD 143.62 M | USD 42.17 M | 228 | |
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | Bridgewater, New Jersey, United States | USD 5.1 B | 13,500 | ||
Pharmaceutical products are developed and marketed globally. | 2009 | Montville, New Jersey, United States | USD 155.92 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Amneal
Complete news archive for Amneal
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Amneal
Amneal was founded in 2002 and raised its 1st funding round 3 years after it was founded.
Amneal is headquartered in Bridgewater, United States. It is registered at Bridgewater, New Jersey, United States.
Amneal has 8,300 employees.
Annual revenue of Amneal is $3.02B as on Dec 31, 2025.
Amneal Pharmaceuticals is a fully-integrated pharmaceutical company focused on the development, manufacture, and distribution of generic and specialty drug products. The company has an extensive portfolio of approximately 250 generic medicines and is expanding its portfolio to include complex dosage forms including biosimilars in a broad range of therapeutic areas. The company also markets a portfolio of branded pharmaceutical products through its specialty segment focused principally on the central nervous system and endocrine disorders.
Amneal offers Generic Products, Specialty Products, and Biosciences Products.
Yes, Amneal is publicly traded on NASDAQ under the ticker symbol AMRX.
Amneal has made 7 acquisitions, including AvKARE, Epsilon Pharmaceuticals, and Gemini Laboratories.
Amneal has 3 investors. Key investors include Northern Trust, GE Capital, and Tarsadia.
Amneal operates through Amneal Pharmaceuticals Llc.
